市場調查報告書
商品編碼
1466355
研究抗體市場:按適應症、按操作、按產品、按來源、按技術、按類型、按最終用戶 - 2024-2030 年,全球預測Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
研究抗體市場規模預計2023年為62.7億美元,預計2024年將達到67.9億美元,2030年將達到110.5億美元,複合年成長率為8.43%。
研究抗體市場是指圍繞科學研究目的抗體的生產、分銷和應用的全球產業。抗體是免疫系統用來辨識和平衡細菌和病毒等外來物質的蛋白質。在研究中,抗體可用於多種應用,包括西方印漬術、流式細胞技術、免疫沉澱、螢光和 ELISA。這些抗體的最終用途通常出現在製藥和生物技術公司、學術研究機構和受託研究機構中。由於它們用途廣泛,市場規模較大,需要開發創新且高度特異性的抗體來滿足多樣化的研究需求。研究抗體市場的成長受到多種因素的影響,包括基因組學和蛋白質組學研究的日益普及、研究抗體的臨床試驗和核准的增加以及製藥和生物技術公司對研發的投資不斷增加。然而,研究抗體市場面臨著諸如高品質研究抗體的高生產和採購成本、與研究抗體相關的品質問題以及關於在抗體生產中使用動物的法規的增加等挑戰。另一方面,個人化醫療和生物標記的普及、開發新藥投資和資金籌措的增加以及從傳統多株抗體到基因工程抗體的轉變將為未來幾年的研究抗體市場帶來潛力。
主要市場統計 | |
---|---|
基準年[2023] | 62.7億美元 |
預測年份 [2024] | 67.9億美元 |
預測年份 [2030] | 110.5億美元 |
複合年成長率(%) | 8.43% |
偏好越來越傾向於免疫學研究抗體,旨在闡明自體免疫疾病
在免疫學中,研究抗體是用於研究免疫系統組成部分的重要工具,包括 T 細胞和 B 細胞等細胞類型、細胞激素等訊號蛋白以及各種免疫途徑。對免疫學的需求通常是由了解自體免疫疾病、過敏和免疫力缺乏的需要所驅動的。用於感染疾病研究的抗體主要用於研究人體對病原體的反應以及識別和表徵病原體本身。整體而言,對抗新出現的感染疾病和流行病的抗體的需求量很大。有效的抗體開發可以改善診斷、疫苗和治療方法。在神經生物學領域,研究抗體促進了腦功能、神經退化性疾病和精神疾病的研究。針對神經元標記物、神經傳導物質和受體的抗體需求量很大,尤其是針對阿茲海默症和帕金森氏症等疾病。抗體對於癌症研究至關重要,包括腫瘤學腫瘤標記識別、癌細胞訊號傳導和免疫腫瘤學。不斷尋求更有效的癌症診斷和治療方法推動了需求。幹細胞研究抗體用於識別和分離幹細胞、區分幹細胞類型並追蹤分化途徑。幹細胞研究是一個快速發展的領域,需求集中在再生醫學和發育生物學研究。比較每個領域的指標表明,根據疾病領域的複雜性和每個領域的進展速度,對研究抗體的需求存在很大差異。由於對抗自體免疫疾病和癌症的持續挑戰,免疫學和腫瘤學是一直需求量大的領域。相反,為了應對新的健康危機,感染疾病的需求通常會激增。神經生物學和幹細胞研究處於科學發現的前沿,需要高度專業化的抗體來解決獨特的研究問題。神經生物學中大腦和中樞神經系統的複雜性以及幹細胞生物學的動態性質需要抗體製造商不斷創新。
最終用戶:擴大研究抗體在製藥和生技公司的使用
學術和研究機構需要抗體用於多種目的,包括基礎研究、疾病研究和教育目的。由於這些機構的研究主題廣泛,他們更喜歡價格實惠且具有多種特異性和用途的抗體。該細分市場專注於教育折扣和機構交易,並且經常尋求大量購買選擇。在製藥和生物技術領域,藥物發現和藥物開發過程需要高品質、高重複性和經過驗證的抗體。他們的需求主要集中在治療性抗體開發、生物標記發現和體外診斷。因此,在高通量和臨床環境中具有保證性能的高級、專用抗體是首選。將學術和研究機構與製藥和生物技術公司進行比較時,研究抗體需求存在一些重要差異。在學術和研究機構,研究主題往往更加多樣化和多樣化,因此抗體需要具有多功能性和成本效益。相較之下,製藥和生技公司優先考慮抗體的重現性和可靠性,特別是當它們在治療研究和診斷方面面臨嚴格的監管要求時。
區域洞察
在美國,對高品質研究抗體的需求強勁,主要是由於大型製藥公司的存在、生物技術和生命科學領域的集中研發工作以及政府和私營部門的大量投資。著名的資助機構美國國立衛生研究院 (NIH) 繼續採取舉措支持生物醫學研究,這對抗體市場產生了積極影響。加拿大市場的特點是生物技術產業不斷發展,政府對醫學研究的資助不斷增加。南美洲的研究抗體市場正在發展,由於醫療保健系統的改善、政府和私人研究支持的增加以及非傳染性疾病的增加,巴西和阿根廷等國家推動了該地區的需求。歐盟國家擁有完善的製藥和生物技術產業以及強大的學術研究活動,因此對研究型抗體的需求很高。然而,嚴格的監管政策可能會限制市場成長。注重研究活動的創新和永續性仍然是歐洲國家(包括英國、英國和法國)的中心趨勢。隨著醫療保健和研究基礎設施投資的增加,中東研究抗體市場正在不斷發展。非洲研究抗體市場相對開拓,具有巨大的成長潛力。由於新興經濟體、醫療保健資金的增加和研究領域的擴大,亞太地區的市場正在快速成長。中國的抗體市場正在快速成長,生物製藥研發投入龐大,學名藥產業蓬勃發展。日本擁有成熟的製藥業和創新傳統,使其成為研究抗體的重要市場。日本以其高標準的研究而聞名,客戶需要具有高特異性和重現性的抗體。印度是一個快速發展的市場,生物相似藥研究激增,生物技術產業蓬勃發展。
FPNV定位矩陣
FPNV定位矩陣對於評估研究抗體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對研究抗體市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.研究抗體市場的市場規模和預測是多少?
2.在研究抗體市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3. 研究抗體市場的技術趨勢和法規結構是什麼?
4.研究抗體市場主要廠商的市場佔有率為何?
5.進入研究型抗體市場的合適型態和策略手段是什麼?
[182 Pages Report] The Research Antibodies Market size was estimated at USD 6.27 billion in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030.
The market for research antibodies refers to the global industry that revolves around the production, distribution, and application of antibodies for scientific research purposes. Antibodies are proteins utilized by the immune system to recognize and balance foreign substances, such as bacteria and viruses. In the research context, antibodies can be used in multiple applications, such as western blotting, flow cytometry, immunoprecipitation, immunofluorescence, and ELISA. The end-use for these antibodies is typically found in pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The broad application base provides a wide market scope, with demand driving the development of innovative and high-specific antibodies for diverse research needs. The growth of the research antibodies market is influenced by several factors, including the rising popularity of genomics and proteomics research, increasing clinical trials and approvals of research antibodies, and heightened investment in R&D by pharmaceutical and biotech firms. However, the research antibodies market faces certain challenges, such as the high cost of production and procurement of high-quality research antibodies, quality concerns associated with research antibodies, and tightening regulations regarding the use of animals in antibody production. On the other hand, the proliferation of personalized medicine and biomarkers, increasing investment and funding for novel drug development, and the shift from traditional polyclonal antibodies to recombinant antibodies present potential opportunities for the research antibodies market in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.27 billion |
Estimated Year [2024] | USD 6.79 billion |
Forecast Year [2030] | USD 11.05 billion |
CAGR (%) | 8.43% |
Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
In immunology, research antibodies are essential tools used to study the components of the immune system, including cell types such as T cells and B cells, signaling proteins, including cytokines, and various immunological pathways. Demand in immunology is frequently driven by the need to understand autoimmune diseases, allergies, and immune deficiencies. Research antibodies for infectious diseases are predominantly utilized to investigate the body's responses to pathogens and to identify and characterize the pathogens themselves. Demand is typically high for antibodies that can help combat emerging infectious diseases and pandemics. Effective antibody development can lead to improved diagnostics, vaccines, and therapies. In the neurobiology segment, research antibodies facilitate the study of brain function, neurodegenerative diseases, and psychiatric disorders. Antibodies against neuronal markers, neurotransmitters, and receptors are in high demand, particularly for illnesses such as Alzheimer's and Parkinson's. Oncology research antibodies are critical for cancer research, including tumor marker identification, cancer cell signaling, and immuno-oncology. Demand is driven by the ongoing search for more effective cancer diagnostics and treatments. Research antibodies directed at stem cells are used to identify and isolate stem cells, differentiate between stem cell types, and track differentiation pathways. Stem cell research is a rapidly progressing field, with demand often focusing on regenerative medicine and developmental biology studies. When comparing indicators across the spectrum, it's apparent that the need for research antibodies varies significantly depending on the complexity of the disease area and the rate of advancements in each field. Immunology and oncology are perennially high-demand sectors due to the ongoing challenges in combating autoimmune diseases and cancer. Conversely, infectious diseases see demand spikes typically in response to emerging health crises. Neurobiology and stem cell research can be categorized as frontiers of scientific discovery, requiring highly specialized antibodies to address unique research challenges. The complexity of the brain and central nervous system in neurobiology and the dynamic nature of stem cell biology necessitates constant innovation from antibody manufacturers.
End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies
Academic and research institutes predominantly require antibodies for various applications such as basic research, disease studies, and educational purposes. These institutions favor antibodies that are both affordable and offer a wide variety of specificities and applications, given the breadth of research topics pursued. This segment often seeks bulk purchasing options, emphasizing educational discounts and institutional deals. The pharmaceutical and biotechnology sector demands high-quality, reproducible, and validated antibodies for drug discovery and development processes. Their needs mainly focus on therapeutic antibody development, biomarker discovery, and in vitro diagnostics. Thus, their preference leans toward premium and specialized antibodies that guarantee performance in high-throughput and clinical settings. When comparing academic and research institutes to pharmaceutical and biotechnology companies, several key differences in research antibody requirements arise. Academic and research institutes often have more diverse and variable research interests, thus seeking versatility and cost-effectiveness in their antibodies. In contrast, pharmaceutical and biotechnology companies prioritize the reproducibility and reliability of antibodies, given the stringent regulatory requirements they face, particularly for therapeutic research and diagnostics.
Regional Insights
In the United States, there is a robust demand for high-quality research antibodies, primarily due to the presence of major pharmaceutical companies, a strong focus on R&D in biotechnology and life sciences, and significant government and private investment. The National Institutes of Health (NIH), a prominent funding body, has a continuing initiative to support biomedical research, which positively impacts the antibody market. Canada's market is characterized by a growing biotechnology industry and increased government funding in medical research. In South America, the research antibodies market is evolving, with countries such as Brazil and Argentina spearheading regional demand due to improving healthcare systems, increased governmental and private support for research, and a rise in non-communicable diseases. EU countries exhibit a strong demand for research antibodies due to well-established pharmaceutical and biotech industries, alongside extensive academic research activities. However, stringent regulatory policies may impose limitations on the market's growth. Focus on innovation and sustainability within research practices remains a central trend in European countries, including Germany, the UK, and France. The research antibody market in the Middle East is evolving with increasing investment in healthcare and research infrastructure. Africa's research antibody market is relatively untapped, with significant potential for growth. The APAC region exhibits rapid market growth due to emerging economies, increased healthcare funding, and expanding research sectors. China's antibody market is rapidly growing, with significant investments in biopharmaceutical R&D and a flourishing generics industry. Japan has an established pharmaceutical sector with a tradition of innovation, making it a significant market for research antibodies. Japan is known for its high standards in research practices, leading customers to demand antibodies with high specificity and reproducibility. India presents a rapidly evolving market with a surge in biosimilar research and a burgeoning biotech industry.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Research Antibodies Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Absolute Antibody Ltd., Agilent Technologies, Inc., AvantGen, Inc., Becton, Dickinson and Company, Bio X Cell, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GenScript Corporation, Jackson ImmunoResearch Inc., Merck KGaA, PerkinElmer, Inc., PROGEN Biotechnik GmbH, Proteintech Group, Inc., QIAGEN N.V., Santa Cruz Biotechnology Inc., Synaptic Systems GmbH, Sysmex Corporation, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Research Antibodies Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies Market?
3. What are the technology trends and regulatory frameworks in the Research Antibodies Market?
4. What is the market share of the leading vendors in the Research Antibodies Market?
5. Which modes and strategic moves are suitable for entering the Research Antibodies Market?